Bortezomib, Vorinostat, and Dexamethasone Combination Therapy in Relapsed Myeloma: Results of the Phase 2 MUK four TrialSarah Brown, Matthew Jenner, Avie‐Lee Tillotson et al.|Clinical Lymphoma Myeloma & Leukemia|2020Cited by 22